Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on equity (ROE) is N/A as of the fiscal period ended Friday, October 31, 2025.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2025-10-31): -216.05%.
RETURN ON EQUITY (ROE)
N/A
RETURN ON EQUITY (ROE) AVG TTM
-290.43%
RETURN ON EQUITY (ROE) AVG 3Y
-258.13%
RETURN ON EQUITY (ROE) AVG 5Y
N/A
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
HeartSciences Inc.
Market Cap
$9.42M
Return on Equity (ROE)
N/A
TTM Avg
-290.43%
3Y Avg
-258.13%
5Y Avg
N/A
Market Cap
$9.63M
Return on Equity (ROE)
-2248.48%
TTM Avg
-970.82%
3Y Avg
-532.13%
5Y Avg
-347.08%
Market Cap
$9.09M
Return on Equity (ROE)
-34.67%
TTM Avg
10.89%
3Y Avg
102.13%
5Y Avg
71.00%
Market Cap
$9.79M
Return on Equity (ROE)
-440.15%
TTM Avg
-145.56%
3Y Avg
-96.97%
5Y Avg
-42.16%
Market Cap
$8.76M
Return on Equity (ROE)
-7.36%
TTM Avg
-85.10%
3Y Avg
-73.72%
5Y Avg
-96.61%
Market Cap
$10.07M
Return on Equity (ROE)
-317.20%
TTM Avg
510.39%
3Y Avg
317.15%
5Y Avg
239.40%
Market Cap
$10.27M
Return on Equity (ROE)
-506.63%
TTM Avg
-300.20%
3Y Avg
-300.20%
5Y Avg
-300.20%
Market Cap
$8.37M
Return on Equity (ROE)
-31.99%
TTM Avg
-84.19%
3Y Avg
-171.49%
5Y Avg
-138.23%
Market Cap
$10.74M
Return on Equity (ROE)
-477.54%
TTM Avg
-207.60%
3Y Avg
64.51%
5Y Avg
-22.91%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HeartSciences Inc. (HSCS) | $9.42M | N/A | -290.43% | -258.13% | N/A |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.63M | -2248.48% | -970.82% | -532.13% | -347.08% |
| Healthcare Triangle, Inc. (HCTI)vs › | $9.09M | -34.67% | 10.89% | 102.13% | 71.00% |
| Ainos, Inc. (AIMD)vs › | $9.79M | -440.15% | -145.56% | -96.97% | -42.16% |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $8.76M | -7.36% | -85.10% | -73.72% | -96.61% |
| SeaStar Medical Holding Corporation (ICU)vs › | $10.07M | -317.20% | 510.39% | 317.15% | 239.40% |
| Caring Brands, Inc. (CABR)vs › | $10.27M | -506.63% | -300.20% | -300.20% | -300.20% |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.37M | -31.99% | -84.19% | -171.49% | -138.23% |
| Cerenome, Inc. (CNSY)vs › | $10.74M | -477.54% | -207.60% | 64.51% | -22.91% |
| Lifeward Ltd. (LFWD)vs › | $10.75M | -252.37% | -195.20% | -116.68% | -90.09% |
ROE
N/A
ROA
N/A
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2025-10-31 | -216.05% |
| 2025-07-31 | -279.15% |
| 2025-01-31 | -476.70% |
| 2024-10-31 | -189.82% |
| 2024-07-31 | -122.85% |
| 2024-04-30 | -90.27% |
| 2024-01-31 | -74.03% |
| 2022-10-31 | -616.20% |
| 2022-07-31 | -204.34% |
